Related references
Note: Only part of the references are listed.Cardiovascular Morbidity in a Randomized Trial Comparing GnRH Agonist and GnRH Antagonist among Patients with Advanced Prostate Cancer and Preexisting Cardiovascular Disease
David Margel et al.
JOURNAL OF UROLOGY (2019)
Evidence of extensive atherosclerosis, coronary artery disease and myocardial infarction in the ApoE-/-:Ins2+/Akita mouse fed a western diet
Daniel E. Venegas-Pino et al.
ATHEROSCLEROSIS (2018)
Sex-Specific Differences in an ApoE-/-:Ins2+/Akita Mouse Model of Accelerated Atherosclerosis
Daniel E. Venegas-Pino et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Treatment with a GnRH receptor agonist, but not the GnRH receptor antagonist degarelix, induces atherosclerotic plaque instability in ApoE-/- mice
Anki Knutsson et al.
SCIENTIFIC REPORTS (2016)
Differences in Hypercholesterolemia and Atherogenesis Induced by Common Androgen Deprivation Therapies in Male Mice
Christian Bo Poulsen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist
Peter C. Albertsen et al.
EUROPEAN UROLOGY (2014)
GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model
Sarah N. Hopmans et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy
Juanita M. Crook et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Spontaneously diabetic Ins2+/Akita: apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis
John Y. Jun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Cardiovascular risk during hormonal treatment in patients with prostate cancer
Hendrik Van Poppel
Cancer Management and Research (2011)
Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden
Mieke Van Hemelrijck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Nancy L. Keating et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Reimbursement Policy and Androgen-Deprivation Therapy for Prostate Cancer.
Vahakn B. Shahinian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The effect of androgen deprivation therapy on body composition in men with prostate cancer: Systematic review and meta-analysis
Farhana Haseen et al.
JOURNAL OF CANCER SURVIVORSHIP (2010)
The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
Laurence Klotz et al.
BJU INTERNATIONAL (2008)
Body composition changes during androgen deprivation therapy for prostate cancer: A 2-year prospective study
Gijsberta J. van Londen et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality
Henry K. Tsai et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
Christopher S. Saigal et al.
CANCER (2007)
Metabolic syndrome and risk of incident cardiovascular events and death - A systematic review and meta-analysis of longitudinal studies
Apoor S. Gami et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Involvement of apolipoprotein E in excess fat accumulation and insulin resistance
Junhong Gao et al.
DIABETES (2007)
Addition of dietary fat to cholesterol in the diets of LDL receptor knockout mice: effects on plasma insulin, lipoproteins, and atherosclerosis
Lan Wu et al.
JOURNAL OF LIPID RESEARCH (2006)
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Nancy L. Keating et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy
Milena Braga-Basaria et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters
Jennifer Yannucci et al.
JOURNAL OF UROLOGY (2006)
Insulin sensitivity during combined androgen blockade for prostate cancer
MR Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Metabolic consequences of physical inactivity
G Biolo et al.
JOURNAL OF RENAL NUTRITION (2005)
Changing patterns in competing causes of death in men with prostate cancer: A population based study
G Lu-Yao et al.
JOURNAL OF UROLOGY (2004)